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Copyright © 2009 JCBN Summary In the present study, we tried to establish an efficient assay for total antioxidant
capacity (TAC) in human plasma using a 96-well microplate. TAC was assessed using lag time
by antioxidants against the myoglobin-induced oxidation of 2,2'-azino-di(3-ethylbenzthiazoline-
6-sulfonic acid (ABTS) with hydrogen peroxide, and expressed as Trolox equivalent. The
linearity of the calibration curve with Trolox was maintained with the Trolox concentration
range from 2.5 µM to 25 µM (R2 = 0.997). The assay was applied to the measurement of TAC
in healthy human plasma. Coefficient of variation in intraday assay was 2.4%. Difference was
not observed in interday assay. Plasma TAC of men ((569 ± 41) µM Trolox equivalent; n =6 )
was higher than that of women ((430 ± 28) µM Trolox equivalent; n = 4). After the vegetable
juice was drunk for 1 week, the increase in plasma TAC was observed in almost all the
volunteers. In summary, we developed the efficient assay for plasma TAC using a 96-well
microplate.
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Introduction
Total antioxidant capacity (TAC) has been used for the
assessment of antioxidant status. Several methods have been
developed for the measurement of TAC; the oxygen radical
absorbance capacity (ORAC) [1], the ferric reducing ability
of plasma (FRAP) [2], the total radical trapping antioxidant
potential (TRAP) [3], and the Trolox equivalent antioxidant
capacity (TEAC) [4]. Most of the assays could not treat
many samples simultaneously. Therefore, it will take long
time to measure TAC of many samples. The development of
an efficient assay for TAC is expected. TAC of many
samples can be measured simultaneously if a 96-well plate is
used for the assay.
The oxidation system of 2,2'-azino-di(3-ethylbenzthiazoline-
6-sulfonic acid (ABTS) by myoglobin with hydrogen
peroxide (H2O2) has been used for TAC assay as TEAC [5].
This is a model system of oxidation by hemeprotein.
Myoglobin reacts with H2O2 and ferrylmyoglobin is formed
(equation 1) [6]. Ferrylmyoglobin oxidizes ABTS to ABTS
cation radical (equation 2; ABTS￿+) and its formation can be
monitored at 600 nm or 734 nm. The oxidation of ABTS is
inhibited via the reaction of Trolox or antioxidants with
ferrylmyoglobin (equation 3) [7]. Trolox also reacts with
ABTS￿+ (equation 4) [8].
Myoglobin (Mb-FeIII)+H 2O2 → 
Ferrylmyoglobin (Mb-FeIV =O )+H 2O (1)
Mb-FeIV =O+A B T S   → Mb-FeIII +A B T S ￿+ (600 nm) (2)Assay for Total Antioxidant Capacity in Plasma
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Mb-FeIV = O + Trolox (Antioxidant) → 
Mb-FeIII + Trolox radical (Antioxidant radical) + −OH (3)
ABTS￿+ + Trolox (Antioxidant) → 
ABTS + Trolox radical (Antioxidant radical) (4)
Therefore, in the present study, we tried to develop an
efficient TAC assay with a 96-well microplate using the
myoglobin-induced oxidation of ABTS and investigated
whether the intake of antioxidants from vegetable juice to
blood was assessed using this assay.
Materials and Methods
Chemicals
H2O2 and ABTS were purchased from Wako Pure
Chemical Industries, Ltd. (Osaka, Japan). Myoglobin (from
equine skeletal muscle) was obtained from Sigma Chemical
Co. (St. Luis, MO). Trolox was from MERK (Darmstadt,
Germany). Solvents and other reagents were of the highest
grade commercially available. Concentration of H2O2 was
calculated with the molar extinction coefficient at 240 nm
(39.4 M−1s−1) [9] using the spectrophotometer (model: UV-
1200; Shimadzu Corp., Kyoto, Japan).
TAC assay
Ninety microliter of 10 mM phosphate-buffered saline
(pH 7.2), 50 μl of myoglobin solution, 20 μl of 3 mM ABTS
solution (final concentration: 300 μM), and 20 μl of diluted
plasma or Trolox solution were added to 8 wells of 96-well
microplate, mixed by vibration, and maintained at 25°C for
3 min. Reaction was started by the addition of H2O2 (20 μl)
and followed at 600 nm with the microplate reader (model:
VERSAmax; Molecular Devices Corp., Sunnyvale, CA) for
5 min (25°C).
To investigate stock duration of plasma for the assay,
plasma was stored at −80°C.
Application of the assay to TAC measurement of human
plasma after the intake of the vegetable juice
All the volunteers gave the informed consent before the
trial was started. Subjects were allowed to continue their
normal dietary habits. The ten healthy subjects (6 men and 4
women, age: 23–41 years) had taken the commercially
available vegetable juice for 1 week (3 bottles per day;
morning, noon, and night). Two hundreds and eighty-five ml
of vegetable juice was contained in a bottle. The concentra-
tions of α-tocopherol, ascorbic acid, β-carotene, and
lycopene in the vegetable juice were 9.0–32.6 μM,
896.5 μM, 32.5–116.6 μM, and 82.3 μM, respectively
(calculation from the data mentioned on a bottle of vegetable
juice). Before and after the trial, blood was drawn from the
antecubital vein into a heparinized syringe before lunch.
Immediately after drawing blood, plasma was prepared by
centrifugation at 3,000 rpm, and then plasma TAC was
measured.
Analysis of uric acid in human plasma
Plasma (10 μl) was mixed with 4 volumes of methanol,
vortexed vigorously for 1 min, and centrifuged at 12,000
rpm for 3 min at 4°C. Methanol extract of plasma (10 μl)
was injected into the HPLC equipped with the UV detector
(model: L-7400; Hitachi, Ltd., Tokyo, Japan). Uric acid
was separated with acetonitrile/40 mM monobasicphosphate
(3/7, v/v) and the CAPCELL PAK NH2 column (2.0 × 150
mm, 5 μm; Shiseido Co., Ltd., Tokyo, Japan) as mobile
phase and column, respectively. Flow rate was 100 μl/min.
Uric acid was monitored at 265 nm.
Statistical analysis
Data on the interday reproducibility of the assay and the
intake of vegetable juice were analyzed using the paired
t-test.
Results
Measurement condition and linearity of the assay
The oxidation of ABTS by myoglobin with H2O2
proceeded linearly as a function of time (Fig. 1). When
inhibitor (such as Trolox) existed in a reaction mixture,
suppression period of ABTS oxidation (lag time) was
observed (Fig. 1). Plasma TAC was assessed using the lag
time and expressed as Trolox equivalent. To determine the
condition for the oxidation of ABTS by myoglobin with
H2O2, various concentrations of myoglobin and H2O2 were
tested. At each concentration of H2O2, the oxidation of
ABTS was in proportion to the concentration of myoglobin
(Fig. 2). The oxidation of ABTS was also in proportion to
the concentration of H2O2. When there is no myoglobin or
H2O2 in the reaction mixture, oxidation of ABTS was not
observed. In various oxidation systems of ABTS using
myoglobin and H2O2, lag times by 10 μM or 20 μM Trolox
Fig. 1. Oxidation of ABTS (300 µM) by myoglobin (4.5 µM)
with H2O2 (250 µM) and its inhibition by Trolox (10 µM)
at 25°C.Y. Kambayashi et al.
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was examined (Fig. 3). Since optimum lag time for the assay
was obtained, 250 μM H2O2 and 4.5 μM myoglobin were
used in the subsequent experiments. Under this condition,
the linearity of the calibration curve with Trolox was
maintained with the Trolox concentration range from
2.5 μM to 25 μM (Fig. 4). The correlate coefficient (R2) was
0.997. Lag time by plasma was linear with dilution range
from 1:25 to 1:50. Plasma diluted 1:50 was used in the
subsequent experiment.
Precision and accuracy of the assay
Precision and accuracy of the assay were assessed with
human plasma. The intraday assay coefficient of variation
(CV) was 1.6 – 4.1% (Table 1). To assess the interday
reproducibility, TACs obtained from the same plasma in
different days were compared (Table 2). No difference was
observed in all the cases tested. Plasma could be stored
for the assay at −80°C for 4 weeks.
Application of the assay
TAC in plasma from the 10 healthy volunteers was
measured before and after the intake of the vegetable juice
for 1 week (Fig. 5). The average of plasma TAC before the
trial was (513 ± 80) μM Trolox equivalent. The difference
was observed between men and women; (569 ± 41)  μM
Trolox equivalent (n = 6) and (430 ± 28)  μM Trolox
equivalent (n = 4), respectively. TAC increased in plasma
of almost all the volunteers after the trial. The average of
plasma TAC was (548 ± 81)  μM Trolox equivalent. No
difference in the increased values of plasma TAC between
men and women was observed (men: (35 ± 25) μM Trolox
equivalent; women: (34 ± 18) μM Trolox equivalent). Uric
Fig. 2. Oxidation of ABTS (300 µM) by various concentrations
of myoglobin with various concentrations of H2O2.
Increase in the absorbance at 600 nm for 5 min (25°C)
was plotted. Results are expressed as mean ± standard
deviation (n =3 ) .
Fig. 3. Relationship between the concentrations of myoglobin
and the lag time by Trolox (A: 10 µM; B: 20 µM) in the
myoglobin-induced oxidation of ABTS (300 µM) at
various concentrations of H2O2 (25°C). Results are
expressed as mean ± standard deviation (n =3 ) .
Fig. 4. Calibration curve with Trolox for the TAC assay. ABTS
(300 µM) was oxidized by myoglobin (4.5 µM) with
H2O2 (250 µM) at 25°C. Results are expressed as
mean ± standard deviation (n =3 ) .
Table 1. Intraday precision values for the TAC assay
Sample 
(human plasma)
TAC (µM Trolox equivalent; n =3 )
CV (%)
Mean SD
A 522 12 2.2
B 406 9 2.3
C 567 9 1.6
D 398 16 4.1
E 596 12 2.0
Table 2. Intrerday reproducibility of the TAC assay
Results are expressed as mean ± standard deviation (n =3 ) .
apaired t test (Day 1 vs Day 2)
Sample 
(human plasma)
TAC (µM Trolox equivalent)
ap value
Day 1 Day 2
a 520 ± 23 525 ± 14 0.824
b 410 ± 14 410 ± 10 0.973
c 500 ± 27 500 ± 46 1.000
d 400 ± 27 400 ± 20 0.991
e 590 ± 10 575 ± 13 0.102Assay for Total Antioxidant Capacity in Plasma
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acid can increase by the metabolic effect of fructose [10].
However, the level of uric acid in plasma did not change
before and after the trial ((366 ± 91) μM and (360 ± 94) μM,
respectively).
Discussion
Many assay for TAC (ORAC [1], FRAP [2], TRAP [3],
and TEAC [4]) have been developed. In most cases, TAC is
assessed by the single point fixed time measurement or the
area under the curve quantitation. However, they are unreli-
able because lag time is observed during oxidation of
substance in the presence of antioxidant as shown in Fig. 1
and oxidation reaction dose not proceed linearly. In such a
case, it is important to follow time course of the reaction to
obtain lag time. The results of the single fixed time measure-
ment were different from those of the measurement using lag
time [11]. Therefore, lag time is better index for TAC and we
used lag time assay for TAC measurement in the present
study.
We used 96-well microplate to examine TAC of many
samples simultaneously in the present study. TAC assays
using 96-well plates have already been reported [12–14].
Moreover, automated TAC assays [15, 16], as a simple TAC
assay, have also been reported. The ABTS￿+ decolorization
method or the crocin bleaching method was used in these
assays and the results were obtained by the single point fixed
time measurement. In these methods, reaction is stopped
when all antioxidants are consumed. In some cases, reaction
may not be stopped when data are recorded. Therefore, to
follow time course of a reaction is also important to obtain
accurate results in these cases. Our assay followed time
course of inhibitory reaction by antioxidants against the
myoglobin-induced oxidation of ABTS.
Since myoglobin, ABTS, and Trolox (or plasma) were
added to each well before reaction was started and incubated
for 3 min, the addition of them to each well did not affect the
lag time for reaction. Time for adding H2O2 and/or recording
data affected the lag time of the reaction when more than 8
wells of 96-well microplate were used simultaneously.
Therefore, we used 8 wells for the simultaneous measure-
ment of TAC.
Oxidative stress is defined as “the disbalance in pro-
oxidant-antioxidant equilibrium in favor of the pro-oxidant”
[17]. Prevention of oxidative damage is important for health
care, because oxidative stress is involved in various diseases
[18]. Biological systems construct defense system using
antioxidants against oxidative stress [19]. Thus, antioxidants
would be used for the prevention of oxidative stress-related
diseases and antioxidant status in plasma would give useful
information for health care. Plasma TAC can be changed by
disease. Serum TACs (measured by the corcin bleaching
method) of inflammatory bowel disease patients or Crohn’s
disease patients are lower than those of normal controls [20].
The level of serum TAC of patients was related with disease
activity and location [20]. Serum TACs (measured by
TRAP) of sepsis patients are higher than those of healthy
controls and correlated with clinical score [21]. Plasma TAC
(measured by the corcin bleaching method) of asymptomatic
carrier of Neisseria meningtidis was lower than those of
healthy control children [22]. Serum TAC (ABTS·+ decolori-
zation method) of hypertension patients was lower than
controls [23]. Therefore, monitoring plasma TAC periodi-
cally would be useful for the health care. Our assay can be
applied for this purpose. The change in TAC in breast milk
after delivery was also reported [24].
Vegetables or fruits have various antioxidants such as
ascorbic acid, β-carotene, polyphenol, and catechin. We
have previously demonstrated that Kinobeon A, purified
from safflower culture cells, showed antioxidant activity
[25,  26]. Thus, the intake of vegetables and fruits (as
antioxidants) is important to prevent oxidative stress-related
diseases. The increase in plasma or serum TAC by the intake
of foods (such as red grape juice [27], strawberries [28],
spinach [28], red wine [28], beer [29], tomato products with
olive oil [30], blueberry [31], chocolate [32], and Mey
flower decoction [33]) and supplements (such as Vitamin C
[28], and vitamin and mineral complex [34,  35]). The
increase in plasma TAC by the intake of vegetable juice
could be assessed using our TAC assay in the present study.
Therefore, our assay would be used for the assessment of the
intake of antioxidants from foods or supplements to blood.
Components giving the increase in plasma TAC after the
intake of vegetable juice were discussed. The concentration
of uric acid, which is main component of plasma TAC, did
not change, but that of ascorbic acid increased in plasma
after the intake of vegetable juice. Contribution of ascorbic
acid to the increase in plasma TAC was roughly calculated
by the depletion of ascorbic acid in plasma using ascorbate
oxidase. The increase in ascorbic acid corresponded to about
Fig. 5. Change in plasma TAC before and after intake of the
vegetable juice for 1 week. Results are expressed as
mean ± standard deviation (n =3 ) .Y. Kambayashi et al.
J. Clin. Biochem. Nutr.
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30% of that in plasma TAC. TAC of plasma, in which uric
acid and ascorbic acid were depleted using uricase and
ascorbate oxidase, also increased after the intake of
vegetable juice. More than twenty kinds of vegetables were
contained in the vegetable juice. Therefore, many anti-
oxidants (including α-tocopherol, β-carotene, and lycopene)
would exist in the vegetable juice and contribute to the
increase in plasma TAC.
In summary, we developed the efficient assay for TAC
using a 96-well microplate. Using this assay, we could assess
the increase in plasma TAC by the intake of the vegetable
juice for 1 week. Our assay would be useful for the health
care and screening for oxidative stress-related diseases by
monitoring plasma TAC.
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